Identification of CD157-Positive Vascular Endothelial Stem Cells in Mouse Retinal and Choroidal Vessels: Fluorescence-Activated Cell Sorting Analysis

PURPOSE. CD157 (also known as Bst1) positive vascular endothelial stem cells (VESCs), which contribute to vascular regeneration, have been recently identified in mouse organs, including the retinas, brain, liver, lungs, heart, and skin. However, VESCs have not been identified in the choroid. The purpose of this study was to identify VESCs in choroidal vessels and to establish the protocol to isolate retinal and choroidal VESCs. METHODS. We established an efficient protocol to create single-cell suspensions from freshly isolated mouse retina and choroid by enzymatic digestion using dispase, collagenase, and type II collagenase. CD157-positive VESCs, defined as CD31(+)CD45(-)CD157(+) cells, were sorted using fluorescence-activated cell sorting (FACS). RESULTS. In mouse retina, among CD31(+)CD45(-) endothelial cells (ECs), 1.6 +/- 0.2% were CD157-positive VESCs, based on FACS analysis. In mouse choroid, among CD31(+)CD45(-) ECs, 4.5 +/- 0.4% were VESCs. The CD157-positive VESCs generated a higher number of EC networks compared with CD157-negative non-VESCs under vascular endothelial growth factor (VEGF) in vitro cultures. The EC network area, defined as the ratio of the CD31-positive area to the total area in each field, was 4.21 +/- 0.39% (retinal VESCs) and 0.27 +/- 0.12% (retinal non-VESCs), respectively (P < 0.01). The EC network area was 8.59 +/- 0.78% (choroidal VESCs) and 0.14 +/- 0.04% (choroidal non-VESCs), respectively (P < 0.01). The VESCs were located in large blood vessels but not in the capillaries. CONCLUSIONS. We confirmed distinct populations of CD157-positive VESCs in both mouse retina and choroid. VESCs are located in large vessels and have the proliferative potential. The current results may open new avenues for the research and treatment of ocular vascular diseases.